Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON47715Completed
Open-label, single-arm trial of grazoprevir and elbasvir in hepatitis C virus infection, sponsored by Ziekenhuisapotheek. Primary endpoints: AUC0-72h geometric mean ratio and AUC0-inf geometric mean ratio. Started Apr 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON47715.